Valophar(SRL)

BE 0508.535.267

	2023		2022		2021		2020
Profit/Loss Section 9904: Profit/Loss of the financial year (after taxes on result) (+/-)	€ 44.459	-11%	€ 50.141	-27%	€ 68.673	91%	€ 35.995
Equity Section 10/15: Equity consists of capital, capital reserves and earnings that remain within the company. These are fully owned by the company and are at its disposal to cover its risks. The better the ratio between equity and debts, the more solvent a company is. A positive equity ratio is important. A negative equity ratio (because of accumulated losses) is a severe warning sign that the continuity of the company may be threatened.	€ 180.249	26%	€ 143.390	71%	€ 83.754	455%	€ 15.081
Gross margin Section 9900: Gross margin or added value is net sales minus the direct costs of the goods sold. In other words: sales invoices minus purchase invoices (70/74 – 60/61). A negative gross margin is a warning sign especially when occurring over several years. It may indicate that the company has insufficient means to cover internal costs like salaries, etc.	€ 193.192	-11%	€ 216.633	1%	€ 214.580	34%	€ 160.220
Employees Section 9087: Average number of staff in full time equivalents	0,9	0%	0,9	0%	0,9		0

	Date	Publication
	29-11-2023	Modification Legal Form - Resignations, Appointments (FR)
	20-12-2012	Rubric Constitution (New Juridical Person, Opening Branch, etc...) (FR)

What is the VAT number of Valophar?

The VAT number of Valophar is BE0508535267.

When was Valophar founded?

Valophar was founded on 18-12-2012.

What is the address of Valophar?

The current registered office of Valophar is located at Rue De La Croix-Rouge Bos. 20, 5032 Gembloux.

When was the last time Valophar filed their annual financial statements?

The most recent financial statements of Valophar were filed on 08-10-2024. You can view them here.

How many employees does Valophar have?

There are 0,9 FTEs working at Valophar according to the staff figures in the most recent financial statements.

What is the annual turnover of Valophar?

At the time of its most recent financial statements, Valophar did not publish any turnover figures. Valophar reported a gross margin of €193,192.23.